1-3 of 3
Krishna Komanduri
Close
Sort by
Journal Articles

Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma

Clinical Trials & Observations
Giuseppe Gritti, Anton Belousov, James Relf, Mark Dixon, Maneesh Tandon, Krishna Komanduri
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3615–3618.
https://doi.org/10.1182/bloodadvances.2023011089
Published: 2024
Includes: Supplemental data
Journal Articles

Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant

Antonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, Trent Wang, Denise Pereira, Mark Goodman, Amer Beitinjaneh, Lazaros Lekakis, Stephanie Chinapen, Sean Devlin, Doris Ponce, Craig Sauter, Miguel-Angel Perales, Brian C. Shaffer
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4491–4500.
https://doi.org/10.1182/bloodadvances.2022007596
Published: 2022
Includes: Supplemental data
Journal Articles

Epidemiology, clinical features, and outcome of HTLV-1–related ATLL in an area of prevalence in the United States

Clinical Trials & Observations
Luis Malpica, Agustin Pimentel, Isildinha M. Reis, Eduardo Gotuzzo, Lazaros Lekakis, Krishna Komanduri, Thomas Harrington, Glen N. Barber, Juan C. Ramos
Journal: Blood Advances
Blood Adv (2018) 2 (6): 607–620.
https://doi.org/10.1182/bloodadvances.2017011106
Published: 2018
Includes: Supplemental data